Skip to content

PHAGEinLYON Clinic Cohort Study: a Descriptive Study of Severe Infections Treated With Phage Therapy at the HCL.

Non Interventional Retrospective and Prospective Single Center Descriptive Study of Severe Infections Treated With Phage Therapy at the Hospices Civils de Lyon (PHAGEinLYON Clinic Cohort Study).

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06185920
Enrollment
250
Registered
2023-12-29
Start date
2023-02-01
Completion date
2034-02-01
Last updated
2023-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Infection

Keywords

bacteriophage, severe infection

Brief summary

PHAGEinLYON Clinic cohort study is a single site non-interventional retrospective and prospective study, initiated by the Hospices Civils de Lyon. Population targeted are patients with a severe infection treated with bacteriophage in the Hospices civils de Lyon from 2015 to 2033. The primary objective is to describe the severe infections treated with phagotherapy. 250 patients will be included in the study.

Interventions

OTHERDescription of severe infection

Description of severe infections treated with bacteriophage in the Hospices Civils de Lyon from 2015 to 2033.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patient with severe infection treated with bacteriophage in the Hospices Civils de Lyon from 01/01/2015 to 01/01/2033 * PHAGEinLYON Clinic cohort study information notice provided to the patient

Exclusion criteria

* Opposition of trial participant

Design outcomes

Primary

MeasureTime frameDescription
Rate of each type of severe infectionthrough study completion (5years)Rate of each type of severe infection treated with bacteriophage in the Hospices Civils de Lyon from 2015 to 2033.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026